20:31 IST
BSE
Management Change
Aarti Drugs Management Change
Aarti Drugs Ltd announced the retirement of Director Uday M. Patil and the appointment of new directors, including Adhish P. Patil as the Managing Director.
Aarti Drugs Ltd
- Share price
- ₹428.80
- Market cap
- ₹3,914 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 20.5×Sector 47.4×
- Promoter holding
- 54.43%-0.60% QoQ
- FII holding
- 1.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Other Announcement 4Legal & Regulatory 3Board Meeting Date 3Results Update 2Management Change 2Financial Results 2Annual General Meeting 2Share Pledge 1Promoter Selling 1Employee Stock Options 1Board Meeting Outcome 1Annual Report 1Adverse Business Impact 1
Time
2 announcements with these filters
20:10 IST
NSE
Management Change
Aarti Drugs Management Change
Aarti Drugs Limited announced the retirement of MD & CEO Prakash M. Patil. The company appointed Rashesh C. Gogri as Chairman and Adhish P. Patil as Managing Director.